Neurosarcoidosis in Critical Care, Internal, and Pulmonary Medicine: A Practical Approach
Seminars in Respiratory and Critical Care Medicine · 01.12.2025 · 46 (06) · 622-640
DOI: 10.1055/a-2768-3052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.12.2025. Verfasst von Munther M Queisi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, U…. Hauptthemen laut MEDLINE: Sarcoidosis, Central Nervous System Diseases, Critical Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, Bart McLean Fund.
Abstract (Originalsprache)
Neurosarcoidosis is a rare but clinically significant manifestation of sarcoidosis, often presenting with diverse neurologic symptoms that can lead to permanent disability if left untreated. This review aims to provide internists, pulmonologists, nonneurologist clinicians, and critical care specialists with a structured, pragmatic approach to the evaluation, diagnosis, and management of neurosarcoidosis in two distinct patient groups: those with a known diagnosis of systemic sarcoidosis and those with no prior history of sarcoidosis. We emphasize the recognition of key acute clinical syndromes such as seizures, stroke, neuroendocrinopathy, hydrocephalus, meningeal disease, myelopathy, and infectious complications that may be encountered in emergency and critical care scenarios. The management approach, which includes first-line therapies such as glucocorticoids and immunomodulatory treatments such as TNF inhibitors and IL-6 inhibitors, is now accepted in the critical care setting to minimize the development of long-standing neurological complications associated with neurosarcoidosis. Furthermore, there is a critical need for a safe and effective transition to steroid-sparing medications for long-term disease control, while closely monitoring the risk for infections, such as tuberculosis and opportunistic infections, metabolic disturbances, and other complications. Given the significance of neurosarcoidosis as a severe manifestation of systemic sarcoidosis, a multidisciplinary approach is essential to effectively manage both neurological and systemic manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
- Division of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Förderung
- NINDS NIH HHS
- NIH HHS
- Bart McLean Fund
- National Institutes of Health
Zitieren
APA
Queisi, M. M., & Pardo, C. A. (2025). Neurosarcoidosis in Critical Care, Internal, and Pulmonary Medicine: A Practical Approach. Seminars in Respiratory and Critical Care Medicine, 46(06), 622-640. https://doi.org/10.1055/a-2768-3052
Vancouver
Queisi MM, Pardo CA. Neurosarcoidosis in Critical Care, Internal, and Pulmonary Medicine: A Practical Approach. Seminars in Respiratory and Critical Care Medicine. 2025;46(06):622-640. doi:10.1055/a-2768-3052
BibTeX
@article{Queisi2025,
author = {Queisi, Munther M and Pardo, Carlos A},
title = {Neurosarcoidosis in Critical Care, Internal, and Pulmonary Medicine: A Practical Approach},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2025},
volume = {46},
number = {06},
pages = {622--640},
doi = {10.1055/a-2768-3052}
}
EUVIMED